NBTY Estimates Lowered By JPMorgan

NBTY NTY, the maker of nutritional supplements, was reiterated as "neutral" with a $42 price target by JPMorgan Chase. Third- and fourth-quarter and full-year 2010 earnings estimates were by JPMorgan to 81 cents, 85 cents $3.57 a share from 93 cents, 99 cents and $3.98 a share. JPMorgan also trimmed its 2011 EPS estimate on NBTY to $3.80 a share from $4.22.